Carlos H Barrios Selected Research

Carlos H Barrios Research Topics

Disease

29	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2005
27	Neoplasms (Cancer) 12/2023 - 02/2010
12	Triple Negative Breast Neoplasms 12/2023 - 11/2018
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2012
7	Renal Cell Carcinoma (Grawitz Tumor) 04/2023 - 02/2010
5	Disease Progression 11/2018 - 04/2013
5	Diarrhea 10/2017 - 12/2012
4	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2015
4	Fatigue 01/2020 - 03/2012
3	Neutropenia 01/2020 - 09/2014
3	Nausea 12/2017 - 03/2016
3	Vomiting 12/2017 - 03/2016
2	Pathologic Complete Response 09/2022 - 01/2022
2	Exanthema (Rash) 02/2016 - 09/2014
1	Microsatellite Instability 09/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Liver Failure 01/2020
1	Autoimmune Hepatitis 01/2020
1	Anemia 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Amenorrhea 01/2019
1	Body Weight (Weight, Body) 04/2018
1	Asthenia 10/2017
1	Headache (Headaches) 10/2017
1	Myocardial Infarction 03/2016
1	Stomach Neoplasms (Stomach Cancer) 03/2016
1	Hand-Foot Syndrome 02/2016
1	Febrile Neutropenia 02/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Ascites 08/2015
1	Carcinoma (Carcinomatosis) 08/2015

Drug/Important Bio-Agent (IBA)

13	Trastuzumab (Herceptin)FDA Link 01/2023 - 10/2005
11	atezolizumabIBA 12/2023 - 11/2018
10	Hormones (Hormone)IBA 01/2023 - 11/2015
8	taxaneIBA 12/2023 - 02/2016
8	130-nm albumin-bound paclitaxelIBA 12/2023 - 11/2018
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2019
6	human ERBB2 proteinIBA 01/2023 - 06/2017
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2012
6	Capecitabine (Xeloda)FDA Link 01/2022 - 05/2010
5	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2015
5	neratinibIBA 01/2023 - 03/2016
5	B7-H1 AntigenIBA 01/2022 - 11/2018
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 09/2014
5	Sunitinib (Sutent)FDA Link 04/2018 - 05/2010
4	LigandsIBA 05/2024 - 10/2020
4	pembrolizumabIBA 12/2023 - 12/2020
4	Ado-Trastuzumab EmtansineIBA 01/2022 - 01/2019
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 08/2013
4	pertuzumabIBA 01/2022 - 06/2017
4	Gemcitabine FDA Link 01/2022 - 04/2010
4	Lapatinib (GW572016)FDA Link 01/2021 - 09/2014
3	CytokinesIBA 04/2023 - 02/2010
3	pazopanib FDA Link 04/2023 - 02/2010
3	PlatinumIBA 01/2021 - 08/2015
3	Monoclonal AntibodiesIBA 10/2020 - 10/2005
2	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2020
2	NivolumabIBA 01/2021 - 04/2018
2	IpilimumabIBA 01/2021 - 04/2018
2	AnthracyclinesIBA 10/2020 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 12/2012
2	Tumor Biomarkers (Tumor Markers)IBA 05/2019 - 01/2019
1	ipatasertibIBA 12/2023
1	ribociclibIBA 01/2023
1	Immunoglobulin G (IgG)IBA 10/2022
1	GlycosphingolipidsIBA 10/2022
1	Immunoglobulin M (IgM)IBA 10/2022
1	Conjugate VaccinesIBA 10/2022
1	Globo-HIBA 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Albumin-Bound Paclitaxel FDA Link 01/2022
1	entrectinibIBA 09/2021
1	larotrectinibIBA 09/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Darbepoetin alfa (Aranesp)FDA Link 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	Formaldehyde (Formol)FDA Link 11/2019
1	ParaffinIBA 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	AfatinibIBA 01/2018
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 10/2017
1	Fulvestrant (Faslodex)FDA Link 10/2017
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2017
1	Alanine Transaminase (SGPT)IBA 02/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2016

Therapy/Procedure

27	Therapeutics 12/2023 - 10/2005
18	Drug Therapy (Chemotherapy) 12/2023 - 10/2005
6	Adjuvant Chemotherapy 01/2023 - 10/2005
3	Immunotherapy 09/2022 - 01/2022
2	Radiotherapy 01/2020 - 03/2012
1	Neoadjuvant Therapy 09/2022
1	Precision Medicine 09/2021
1	Consolidation Chemotherapy 01/2018
1	Nephrectomy 01/2016